At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 14 enrolled
Drug / intervention
Midazolam +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1, Open-label, 1-sequence Crossover, Drug-drug Interaction Study to Assess the Effect of Repeated Doses of Cefiderocol on the Pharmacokinetics of Midazolam in Healthy Adult Participants
In Brief
A Phase 1 clinical trial evaluating Midazolam and Cefiderocol for Healthy Volunteers. Completed, enrolled 14 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the effect of repeated doses of cefiderocol on the PK of midazolam.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
2023202420252026
Enrollment StartMay 2022
First PostedMay 2022
Primary CompletionJul 2022
TodayJul 2026
First PostedMay 27, 2022
Enrollment StartMay 24, 2022
Primary CompletionJul 13, 2022
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 4.1 years ago
Interventions
Midazolamdrug
Syrup for oral administration
Cefiderocoldrug
Liquid for intravenous infusion